Nilai pasar: Alpha Cognition Inc (ACOG)

Alpha Cognition (ACOG) focuses on developing oral medications for dementia and other brain impairments, mitigating risks through an extensive portfolio of tests. This price action for the company on GURU.Markets is 0.19. Revenue is based on the sale of cognitive treatments via government programs and insurance. Sales stability is ensured by proven distribution channels and strategic raw material stockpiling.

Alpha Cognition Inc - Kapitalisasi pasar ACOG (periode 13.11.2024 - 22.10.2026)

ACOG (alphacognition.com): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Alpha Cognition (ACOG):

Rega saham Alpha Cognition Inc.|ACOG - Target konsensus|Nilai pasar Alpha Cognition Inc.

Analisis fundamental perusahaan:ACOG (Alpha Cognition Corp)

Sampel barang Alpha Cognition Inc

The scale of Alpha Cognition (ACOG) is defined by the uniqueness of its developments in Alzheimer's disease therapy. Market capitalization, calculated as the share price multiplied by the total number of shares, measures the aggregate value of the business in the eyes of the market. Investors evaluate this indicator to weigh speculative noise against the real value of patent barriers and FDA approval. The stability of the company's total equity value confirms the fundamental strength of its assets. This chart's dynamics allow for the timely recognition of a shift in valuation trends.

Pesaing wigati

Kapitalisasi pasar BIIB (Biogen)|NBIX - Biji pasar|RGC - Nilai pasar|Nilai pasar Axsome Corp|ACAD: Kapitalisasi pasar|Kapitalisasi pasar xenon-pharma.com XENE|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|CBLL (CeriBell, Inc.) - Kapitalisasi pasar|Kapitalisasi pasar Prothena Corp|Nilai pasar Alector, Inc. (ALEC)|Nilai pasar ANNX (Annexon Biosciences)|Nilai pasar Omeros OMER|NGNE (Neurogene Therapeutics) - Biji pasar|AC Immune - Kapitalisasi pasar|Nilai pasar VYGR (voyagertherapeutics.com)|NMRA: Kapitalisasi pasar|Scilex Holding (SCLX) - Kapitalisasi pasar|Biji pasar TVGN|CGTX: Nilai pasar|Kapitalisasi pasar IKT|Biji pasar cassavasciences.com SAVA|Nilai pasar Assertio ASRT|Coya Therapeutics Inc (COYA) - Nilai pasar|VistaGen Therapeutics Inc - Kapitalisasi pasar|Kapitalisasi pasar Ovid Therapeutics Inc. (OVID)|Acumen Pharmaceuticals (ABOS) - Nilai pasar|Kapitalisasi pasar CRVO|ATHE (Alterity Therapeutics Ltd.) - Kapitalisasi pasar|Clene Nanomedicine (CLNN) - Kapitalisasi pasar|Biji pasar PEPG (PepGen Inc.)|Nilai pasar JUNS|Kapitalisasi pasar RLMD (Relmada Therapeutics)|Kapitalisasi pasar annovisbio.com (ANVS)|GRCE - Nilai pasar|Nilai pasar Firefly Neuroscience, Inc.|anewmeds.com (KLTO) - Nilai pasar|Kapitalisasi pasar NRSN|RVPH (Reviva Pharmaceuticals) - Kapitalisasi pasar|Kapitalisasi pasar MetaVia, Inc.|Kapitalisasi pasar NRXS|Biji pasar heliusmedical.com HSDT|Nilai pasar Passage Bio PASG|Neuphoria Therapeutics, Inc. (NEUP) - Nilai pasar|Minerva Neurosciences - Kapitalisasi pasar|Kapitalisasi pasar athira.com (ATHA)|Addex Therapeutics Ltd (ADXN) - Nilai pasar|Kapitalisasi pasar ALZN|CYCN (Cyclerion Therapeutics Inc.) - Kapitalisasi pasar|Nilai pasar Protagenic PTIX|Biji pasar KTTA (Pasithea Therapeutics)|Kapitalisasi pasar cortigent.com (CRGT)|Nilai pasar Avenue Therapeutics, Inc. ATXI|Nilai pasar BCLI|CARA - Nilai pasar|Nilai pasar Chromocell|ELYM: Kapitalisasi pasar|Intra-Cellular Therapies, Inc. (ITCI) - Kapitalisasi pasar|Nilai pasar Longboard Pharmaceuticals, Inc.|Nilai pasar MRNS|Nilai pasar NKGen (NKGN)|NRBO: Biji pasar|Kapitalisasi pasar SAGE (Sage Therapeutics, Inc.)|Nilai pasar SNPX|Trevena - Kapitalisasi pasar|VIGL - Kapitalisasi pasar|WENA (Anew Medical, Inc.) - Biji pasar|Cerevel Corp - Nilai pasar